Author

Christine Beham‐Schmid

Observed names: Beham- Schmid Christine, Beham-Schmid, Christine, C Beham-Schmid, C Beham‐Schmid, C. Beham-Schmid, C. Beham‐Schmid, CHRISTINE BEHAM-SCHMID, Ch. Beham‐Schmid, Christine Beham-Schmid, Christine Beham-Schmidt, Christine Beham-schmid, Christine Beham–Schmid

Institution: Research Institute of Molecular Pathology

Observed institutions: University of Vienna, Karolinska University Hospital, University of Graz, University of Basel, Research Institute of Molecular Pathology, Medical University of Graz, University Hospital of Basel, Graz University Hospital, Universitätsklinik für Frauenheilkunde und Geburtshilfe, Kaiser-Franz-Josef-Spital, St Anna Children's Hospital, LKH Hochsteiermark, Ryhov Hospital Jönköping, St. Anna Children's Cancer Research Institute, Medical University of Vienna

OpenAlex ID: A5108394602

Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation

2014 · Andreas Reinisch, Nathalie Etchart, et al. · Blood · 270

Specific cutaneous infiltrates in patients with myelogenous leukemia: A clinicopathologic study of 26 patients with assessment of diagnostic criteria

1999 · Steven Kaddu, Paul Zenahlik, et al. · Journal of the American Academy of Dermatology · 208

Nasopharyngeal Angiofibroma: True Neoplasm or Vascular Malformation?

2000 · Alfred Beham, Christine Beham-Schmid, et al. · Advances in Anatomic Pathology · 141

Treatment of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type With Cladribine: A Phase II Study

2002 · Gerald Jäger, Peter Neumeister, et al. · Journal of Clinical Oncology · 137

Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis

2002 · Christine Beham-Schmid, Ute Apfelbeck, et al. · Blood · 125

PDF

Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms

2012 · Eduard Schulz, Angelika Valentin, et al. · Journal of Medical Genetics · 113

Keratoacanthoma

1998 · Alfred Beham, Sigrid Regauer, et al. · Advances in Anatomic Pathology · 104

Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis – a consensus‐based study

2015 · Hans Michael Kvasnicka, Christine Beham‐Schmid, et al. · Histopathology · 90

PDF

The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma

2013 · K Troppan, A Deutsch, et al. · British Journal of Cancer · 84

PDF

Trichoblastic Carcinoma (“Malignant Trichoblastoma”) with Lymphatic and Hematogenous Metastases

2000 · Sigrid Regauer, Christine Beham-Schmid, et al. · Modern Pathology · 83

PDF

Colchicine poisoning by accidental ingestion of meadow saffron (Colchicum autumnale): pathological and medicolegal aspects

1999 · Michael Klintschar, Christine Beham-Schmidt, et al. · Forensic Science International · 82

Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas

1997 · P Neumeister, G Hoefler, et al. · Gastroenterology · 82

PDF

Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma

2012 · Alexander JA Deutsch, Elisabeth Steinbauer, et al. · Modern Pathology · 79

Monoclonal γ-T-Cell Receptor Rearrangement in Vulvar Lichen Sclerosus and Squamous Cell Carcinomas

2002 · Sigrid Regauer, Olaf Reich, et al. · American Journal Of Pathology · 76

PDF

MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation

2006 · Alexander J. A. Deutsch, Ariane Aigelsreiter, et al. · Blood · 75

Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia

2004 · Philipp Bernhard Staber, Werner Linkesch, et al. · Oncogene · 74

Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

2017 · Georg Jeryczynski, Jürgen Thiele, et al. · American Journal of Hematology · 68

PDF

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

2014 · K T Troppan, K Schlick, et al. · British Journal of Cancer · 66

PDF

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

2015 · H Gisslinger, G Jeryczynski, et al. · Leukemia · 63

PDF

Cutaneous Hodgkin's disease: an immunohistochemical analysis

1995 · Lorenzo Cerroni, Christine Beham‐Schmid, et al. · Journal of Cutaneous Pathology · 63

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing

2017 · Karl Kashofer, Max Gornicec, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 61

Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X

2014 · Eduard Schulz, Petra Klampfl, et al. · Nature Communications · 61

PDF

Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS)

2010 · Peter Valent, Attilio Orazi, et al. · Oncotarget · 60

PDF

miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients

2015 · Katharina Troppan, Kerstin Wenzl, et al. · International Journal of Molecular Sciences · 56

PDF

The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress

2010 · Holger W. Auner, Christine Beham-Schmid, et al. · Blood · 56

Works count: 233

Citation count: 4,479

H-index: 39

I10-index: 91